Sargent Bickham Lagudis’s Cardiovascular Systems, Inc. CSII Stock Holding History

Sargent Bickham Lagudis’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.36K	Hold	100	–	–	﹤0.01%	946
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	963
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	1040
2022 Q1	$2K	Hold	100	–	–	﹤0.01%	905
2021 Q4	$2K	Hold	100	–	–	﹤0.01%	899
2021 Q3	$3K	Hold	100	–	–	﹤0.01%	875
2021 Q2	$4K	Hold	100	–	–	﹤0.01%	829
2021 Q1	$4K	Hold	100	–	–	﹤0.01%	824
2020 Q4	$4K	Hold	100	–	–	﹤0.01%	770
2020 Q3	$4K	Hold	100	–	–	﹤0.01%	689
2020 Q2	$3K	Hold	100	–	–	﹤0.01%	694
2020 Q1	$4K	Buy	+100	New	+$4.21K	﹤0.01%	667

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sargent Bickham Lagudis's CSII Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Cardiovascular Systems, Inc. (CSII) position steady in Q4 2022 at 100 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #946.

Sargent Bickham Lagudis first reported a position in CSII in Q1 2020 and has held it in 12 quarters since. The position peaked at $4K in Q2 2021. 161 funds tracked by Wall St. Rank hold CSII as of Q4 2022.

Sargent Bickham Lagudis held 100 shares of Cardiovascular Systems, Inc. worth $1.36K as of Q4 2022.
Sargent Bickham Lagudis left its Cardiovascular Systems, Inc. share count unchanged in Q4 2022.
Cardiovascular Systems, Inc. made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #946 holding.
Sargent Bickham Lagudis first reported a position in Cardiovascular Systems, Inc. in Q1 2020 and has held it in 12 quarters since.
Sargent Bickham Lagudis's Cardiovascular Systems, Inc. position peaked at $4K in Q2 2021.
161 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.